[1]
M. Defina, “PERSISTENCE OF PH+/CD34+ CELLS IN CHRONIC MYELOID LEUKEMIA PATIENTS IN PROLONGED COMPLETE CYTOGENETIC REMISSION FOLLOWING IMATINIB MESYLATE TREATMENT”, J Siena Acad Sci, vol. 1, no. 1, pp. 15–17, Jan. 2012.